Shanghai Rendu Biotechnology Co. Ltd. A Capital Reinvestment Ratio
Shanghai Rendu Biotechnology Co. Ltd. A capital reinvestment ratio. Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥22.41 Million) in capital expenditures (CN¥7.07 Million). Check 688193 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Capital reinvestment ratio of Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025. This chart tracks Shanghai Rendu Biotechnology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Also explore how fast is Shanghai Rendu Biotechnology Co. Ltd. A growing its equity to track the company's year-over-year net asset growth rate.
Shanghai Rendu Biotechnology Co. Ltd. A Capital Reinvestment Ratio by Year (2019–2025)
Shanghai Rendu Biotechnology Co. Ltd. A capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Shanghai Rendu Biotechnology Co. Ltd. A operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥22.41 Million | CN¥7.07 Million | ▼ -26.8% |
| 2024 | 0.43x | CN¥24.39 Million | CN¥10.52 Million | ▼ -63.6% |
| 2023 | 1.19x | CN¥17.19 Million | CN¥20.39 Million | ▲ +143.9% |
| 2021 | 0.49x | CN¥54.44 Million | CN¥26.48 Million | ▲ +189.7% |
| 2020 | 0.17x | CN¥92.61 Million | CN¥15.55 Million | ▼ -95.8% |
| 2019 | 4.01x | CN¥13.67 Million | CN¥54.83 Million | — |